Both H2020 projects (EFICONSUMPTION Phase 1 and Phase 2) address the same core problem: reducing electrical energy consumption in industrial plants.
CYSNERGY SL
Spanish technology SME with EU-validated system for reducing electrical energy consumption in industrial manufacturing plants.
Their core work
CYSNERGY SL is a Spanish technology SME based in Paterna (Valencia) that develops systems for improving electrical energy efficiency in industrial plants. Their flagship product, EFICONSUMPTION, is an innovative solution targeting energy waste reduction at the industrial facility level — a commercially significant problem for energy-intensive manufacturers. They successfully progressed through the competitive EU SME Instrument program, first validating the concept in a Phase 1 feasibility study (2014–2015) and then executing a full commercialization project in Phase 2 (2016–2018), which is a meaningful signal of both technical credibility and business case strength. Their work sits at the intersection of industrial automation and energy management.
What they specialise in
The EFICONSUMPTION system implies sensing, measurement, and control capabilities needed to diagnose and manage energy flows at plant level.
Energy efficiency systems for industrial plants typically require integration with plant control infrastructure, suggesting embedded or IoT-adjacent capabilities — though this is inferred, not confirmed by keyword data.
How they've shifted over time
CYSNERGY's entire H2020 history is a single sustained focus: electrical energy efficiency in industrial plants, pursued from 2014 to 2018. There is no detectable shift in topic — both projects share the same title and problem domain, representing Phase 1 and Phase 2 of the same innovation journey. Without activity after 2018 in the H2020 dataset, it is not possible to determine whether they expanded into adjacent areas such as renewables integration, demand response, or industrial decarbonization — directions common for companies in this space post-2020.
CYSNERGY shows deep, single-product focus rather than portfolio expansion — a company that bet on one solution and took it through full EU commercialization validation; future collaboration potential depends heavily on whether EFICONSUMPTION evolved post-2018.
How they like to work
CYSNERGY has operated exclusively as a solo applicant through the SME Instrument program, which by design requires no consortium partners. This means they have zero recorded collaboration history within H2020 — not a sign of unwillingness to collaborate, but simply a reflection of the funding instrument they used. If approached for a consortium, they would likely enter as a technology contributor bringing a validated commercial product rather than as a research partner; their experience coordinating their own EU projects suggests administrative capacity to handle project obligations independently.
CYSNERGY has no recorded consortium partners across their two H2020 projects, as both were awarded under the SME Instrument scheme which does not require partner organizations. Their collaboration network within EU-funded research is effectively non-existent in the available data.
What sets them apart
CYSNERGY is one of the few Spanish SMEs to have successfully completed the full SME Instrument Phase 1 → Phase 2 journey in the energy efficiency space — a progression that required passing two separate competitive evaluations by the European Commission. This distinguishes them from research organizations or larger firms: they built a commercially-oriented product with EU validation, not a research prototype. For a consortium looking for an industrial energy efficiency component provider with a proven commercialization track record, CYSNERGY brings validated market-facing credentials that university partners typically cannot offer.
Highlights from their portfolio
- EFICONSUMPTION (Phase 2)The largest project by far at €902,038 EC funding, this SME Instrument Phase 2 award represents a full commercialization grant — the EU's competitive endorsement that the EFICONSUMPTION system had both technical merit and real market potential.
- EFICONSUMPTION (Phase 1)The €50,000 feasibility study that unlocked Phase 2 — notable because the Phase 1 → Phase 2 conversion rate in the SME Instrument was below 10%, making this progression a meaningful competitive achievement.